BPC
CC icon

Bryce Point Capital’s Chemours CC Stock Holding History

Bryce Point Capital’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$660K Sell
41,661
-41,768
-50% -$606K 0.81% 14
2025
Q2 		$955K Buy
+83,429
New +$940K 0.81% 18

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bryce Point Capital's CC Position: Q3 2025 in Review

Bryce Point Capital reduced its Chemours (CC) stake by 50% in Q3 2025, selling an estimated $606K and leaving 41,661 shares worth $660K. The position accounts for 0.81% of the portfolio, ranked #14.

Bryce Point Capital first reported a position in CC in Q2 2025 and has held it in 2 quarters since. The position peaked at $955K in Q2 2025. 428 funds tracked by Wall St. Rank hold CC as of Q3 2025.

  • Bryce Point Capital held 41,661 shares of Chemours worth $660K as of Q3 2025.
  • Bryce Point Capital sold 41,768 Chemours shares in Q3 2025, an estimated $606K.
  • Chemours made up 0.81% of Bryce Point Capital's portfolio in Q3 2025, its #14 holding.
  • Bryce Point Capital first reported a position in Chemours in Q2 2025 and has held it in 2 quarters since.
  • Bryce Point Capital's Chemours position peaked at $955K in Q2 2025.
  • 428 funds tracked by Wall St. Rank held Chemours as of Q3 2025.

Based on Bryce Point Capital's 13F filing for Q3 2025, filed 6 Nov 2025.